Microbiology, genomics, and clinical significance of the Pseudomonas fluorescens species complex, an unappreciated colonizer of humans.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 4187640)

Published in Clin Microbiol Rev on October 01, 2014

Authors

Brittan S Scales1, Robert P Dickson2, John J LiPuma3, Gary B Huffnagle4

Author Affiliations

1: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
2: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
3: Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA.
4: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA ghuff@umich.edu.

Associated clinical trials:

Lung HIV Microbiome Project (Michigan Site) (LHMP) | NCT02392182

Articles cited by this

(truncated to the top 100)

Two simple media for the demonstration of pyocyanin and fluorescin. J Lab Clin Med (1954) 63.14

MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res (2002) 47.62

MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol (2013) 34.34

MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res (2005) 31.64

Recent developments in the MAFFT multiple sequence alignment program. Brief Bioinform (2008) 22.07

Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J Bacteriol (1994) 17.55

Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol (1998) 17.38

DNA-DNA hybridization values and their relationship to whole-genome sequence similarities. Int J Syst Evol Microbiol (2007) 12.76

Novel small RNA-encoding genes in the intergenic regions of Escherichia coli. Curr Biol (2001) 7.56

Quorum-sensing in Gram-negative bacteria. FEMS Microbiol Rev (2001) 6.93

Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J (1994) 6.37

Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol (2003) 6.23

phyloXML: XML for evolutionary biology and comparative genomics. BMC Bioinformatics (2009) 6.02

An expanding universe of noncoding RNAs. Science (2002) 5.96

Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol Microbiol (1994) 5.82

Iron absorption and transport in microorganisms. Annu Rev Nutr (1981) 5.52

Biological control of soil-borne pathogens by fluorescent pseudomonads. Nat Rev Microbiol (2005) 5.45

Initiation of Plant Disease Resistance by Physical Interaction of AvrPto and Pto Kinase Science (1996) 5.06

Molecular Basis of Gene-for-Gene Specificity in Bacterial Speck Disease of Tomato Science (1996) 4.80

Complete genome sequence of the plant commensal Pseudomonas fluorescens Pf-5. Nat Biotechnol (2005) 4.65

The viable but nonculturable state in bacteria. J Microbiol (2005) 4.52

Gene cluster of Pseudomonas syringae pv. "phaseolicola" controls pathogenicity of bean plants and hypersensitivity of nonhost plants. J Bacteriol (1986) 4.38

The global activator GacA of Pseudomonas aeruginosa PAO positively controls the production of the autoinducer N-butyryl-homoserine lactone and the formation of the virulence factors pyocyanin, cyanide, and lipase. Mol Microbiol (1997) 4.33

Phylogenetic affiliation of the pseudomonads based on 16S rRNA sequence. Int J Syst Evol Microbiol (2000) 4.31

Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol (2005) 4.28

Small talk. Cell-to-cell communication in bacteria. Cell (2002) 4.27

Membrane traffic wardens and protein secretion in gram-negative bacteria. Trends Biochem Sci (1993) 4.07

Isolation of 2,4-diacetylphloroglucinol from a fluorescent pseudomonad and investigation of physiological parameters influencing its production. Appl Environ Microbiol (1992) 3.92

Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology (2000) 3.90

Genomic and genetic analyses of diversity and plant interactions of Pseudomonas fluorescens. Genome Biol (2009) 3.63

Ecological Similarity and Coexistence of Epiphytic Ice-Nucleating (Ice) Pseudomonas syringae Strains and a Non-Ice-Nucleating (Ice) Biological Control Agent. Appl Environ Microbiol (1994) 3.58

Survival of rifampin-resistant mutants of Pseudomonas fluorescens and Pseudomonas putida in soil systems. Appl Environ Microbiol (1988) 3.52

Evaluation of 16S rDNA-based community profiling for human microbiome research. PLoS One (2012) 3.49

Comparative genomics of plant-associated Pseudomonas spp.: insights into diversity and inheritance of traits involved in multitrophic interactions. PLoS Genet (2012) 3.46

Global control in Pseudomonas fluorescens mediating antibiotic synthesis and suppression of black root rot of tobacco. Proc Natl Acad Sci U S A (1992) 3.39

Predation on prokaryotes in the water column and its ecological implications. Nat Rev Microbiol (2005) 3.36

Opportunistic pathogens enriched in showerhead biofilms. Proc Natl Acad Sci U S A (2009) 3.35

Pathogenic fungus harbours endosymbiotic bacteria for toxin production. Nature (2005) 3.34

Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology (2002) 3.21

Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother (1985) 3.19

Pseudomonas genomes: diverse and adaptable. FEMS Microbiol Rev (2011) 2.96

Regulatory RNA as mediator in GacA/RsmA-dependent global control of exoproduct formation in Pseudomonas fluorescens CHA0. J Bacteriol (2002) 2.86

Exploitation of gene(s) involved in 2,4-diacetylphloroglucinol biosynthesis to confer a new biocontrol capability to a Pseudomonas strain. Appl Environ Microbiol (1992) 2.78

Phylogeny of the genus Pseudomonas: intrageneric structure reconstructed from the nucleotide sequences of gyrB and rpoD genes. Microbiology (2000) 2.73

Antisense RNAs in bacteria and their genetic elements. Adv Genet (2002) 2.68

Molecular basis of plant growth promotion and biocontrol by rhizobacteria. Curr Opin Plant Biol (2001) 2.59

Genomics of secondary metabolite production by Pseudomonas spp. Nat Prod Rep (2009) 2.54

Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol (2004) 2.53

DNA sequence-based analysis of the Pseudomonas species. Environ Microbiol (2010) 2.53

The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol Med (2004) 2.48

Expression stability of six housekeeping genes: A proposal for resistance gene quantification studies of Pseudomonas aeruginosa by real-time quantitative RT-PCR. J Med Microbiol (2003) 2.46

Database-driven multi locus sequence typing (MLST) of bacterial pathogens. Bioinformatics (2001) 2.45

Type III protein secretion mechanism in mammalian and plant pathogens. Biochim Biophys Acta (2004) 2.44

Phenazine natural products: biosynthesis, synthetic analogues, and biological activity. Chem Rev (2004) 2.37

Phenazine compounds in fluorescent Pseudomonas spp. biosynthesis and regulation. Annu Rev Phytopathol (2006) 2.31

Adaptation of Pseudomonas fluorescens to the plant rhizosphere. Environ Microbiol (1999) 2.26

Conservation of the 2,4-diacetylphloroglucinol biosynthesis locus among fluorescent Pseudomonas strains from diverse geographic locations. Appl Environ Microbiol (1996) 2.25

Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase. Biochem J (1980) 2.24

Natural functions of lipopeptides from Bacillus and Pseudomonas: more than surfactants and antibiotics. FEMS Microbiol Rev (2010) 2.21

Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol (2009) 2.17

Contaminated lithium heparin bottles as a source of pseudobacteraemia due to Pseudomonas fluorescens. J Hosp Infect (1999) 2.17

The rpoB gene as a tool for clinical microbiologists. Trends Microbiol (2008) 2.12

Toward a more robust assessment of intraspecies diversity, using fewer genetic markers. Appl Environ Microbiol (2006) 2.07

A c-di-GMP effector system controls cell adhesion by inside-out signaling and surface protein cleavage. PLoS Biol (2011) 2.05

Pseudomonic acid: an antibiotic produced by Pseudomonas fluorescens. Nature (1971) 2.05

Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation (2008) 2.05

Extracellular protease and phospholipase C are controlled by the global regulatory gene gacA in the biocontrol strain Pseudomonas fluorescens CHA0. FEMS Microbiol Lett (1994) 2.03

Molecular recognition of pathogen attack occurs inside of plant cells in plant disease resistance specified by the Arabidopsis genes RPS2 and RPM1. Proc Natl Acad Sci U S A (1996) 2.02

The sigma factor sigma s affects antibiotic production and biological control activity of Pseudomonas fluorescens Pf-5. Proc Natl Acad Sci U S A (1995) 2.02

Small RNAs in bacteria: diverse regulators of gene expression in response to environmental changes. Cell (2002) 2.00

Identification of Pseudomonas species isolated from hospital environment and human sources. Appl Microbiol (1968) 2.00

Autoinduction of 2,4-diacetylphloroglucinol biosynthesis in the biocontrol agent Pseudomonas fluorescens CHA0 and repression by the bacterial metabolites salicylate and pyoluteorin. J Bacteriol (2000) 1.94

Structural basis for c-di-GMP-mediated inside-out signaling controlling periplasmic proteolysis. PLoS Biol (2011) 1.93

Playing Dr Jekyll and Mr Hyde: combined mechanisms of phase variation in bacteria. Curr Opin Microbiol (2001) 1.93

Adding unaligned sequences into an existing alignment using MAFFT and LAST. Bioinformatics (2012) 1.90

Pore-forming activity of type III system-secreted proteins leads to oncosis of Pseudomonas aeruginosa-infected macrophages. Mol Microbiol (2001) 1.79

Characterization of the hcnABC gene cluster encoding hydrogen cyanide synthase and anaerobic regulation by ANR in the strictly aerobic biocontrol agent Pseudomonas fluorescens CHA0. J Bacteriol (1998) 1.79

Microbiology of human and animal bite wounds in children. Pediatr Infect Dis J (1987) 1.74

Evolutionary relationships of pathogenic clones of Vibrio cholerae by sequence analysis of four housekeeping genes. Infect Immun (1999) 1.73

Isolation and growth of a Pseudomonas species that utilizes cyanide as a source of nitrogen. J Gen Microbiol (1983) 1.73

The Crohn's disease-associated bacterial protein I2 is a novel enteric t cell superantigen. Immunity (2001) 1.69

The reach of the genome signature in prokaryotes. BMC Evol Biol (2006) 1.69

Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines. Cancer Res (1986) 1.68

Specificity of pyoverdine-mediated iron uptake among fluorescent Pseudomonas strains. J Bacteriol (1988) 1.67

On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J Antibiot (Tokyo) (1978) 1.67

Historical evolution and current status of the taxonomy of genus Pseudomonas. Infect Genet Evol (2009) 1.66

Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia. J Clin Microbiol (2007) 1.65

Pseudomonas protegens sp. nov., widespread plant-protecting bacteria producing the biocontrol compounds 2,4-diacetylphloroglucinol and pyoluteorin. Syst Appl Microbiol (2011) 1.64

The viable but non-culturable state in the human pathogen Vibrio vulnificus. FEMS Microbiol Lett (1995) 1.64

The biocontrol strain Pseudomonas fluorescens F113 produces the Rhizobium small bacteriocin, N-(3-hydroxy-7-cis-tetradecenoyl)homoserine lactone, via HdtS, a putative novel N-acylhomoserine lactone synthase. Microbiology (2000) 1.63

Iron uptake and metabolism in pseudomonads. Appl Microbiol Biotechnol (2010) 1.62

Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients. Diagn Microbiol Infect Dis (1985) 1.61

Amplification of the housekeeping sigma factor in Pseudomonas fluorescens CHA0 enhances antibiotic production and improves biocontrol abilities. J Bacteriol (1995) 1.57

Eat, kill or die: when amoeba meets bacteria. Curr Opin Microbiol (2008) 1.56

RsmY, a small regulatory RNA, is required in concert with RsmZ for GacA-dependent expression of biocontrol traits in Pseudomonas fluorescens CHA0. Mol Microbiol (2003) 1.55

Salicylic Acid Biosynthetic Genes Expressed in Pseudomonas fluorescens Strain P3 Improve the Induction of Systemic Resistance in Tobacco Against Tobacco Necrosis Virus. Phytopathology (1998) 1.52

A study of bacteria implicated in transfusion reactions and of bacteria isolated from blood products. J Lab Clin Med (1953) 1.50

Impact of protozoan grazing on bacterial community structure in soil microcosms. Appl Environ Microbiol (2002) 1.49

Iron uptake regulation in Pseudomonas aeruginosa. Biometals (2009) 1.48

Type III secretion in plant growth-promoting Pseudomonas fluorescens SBW25. Mol Microbiol (2001) 1.44

Articles by these authors

Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio (2015) 1.56

Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J Clin Microbiol (2014) 1.00

In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients. Antimicrob Agents Chemother (2014) 0.86

Draft Genome Sequences of Seven Pseudomonas fluorescens Subclade III Strains Isolated from Cystic Fibrosis Patients. Genome Announc (2015) 0.81

Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms. Antimicrob Agents Chemother (2015) 0.78

Effect of High-Dose Antimicrobials on Biofilm Growth of Achromobacter Species Isolated from Cystic Fibrosis Patients. Antimicrob Agents Chemother (2015) 0.77

Draft Genome Sequences of Five Pseudomonas fluorescens Subclade I and II Strains, Isolated from Human Respiratory Samples. Genome Announc (2015) 0.77

A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs. J Leukoc Biol (2016) 0.75

Making It Last: Storage Time and Temperature Have Differential Impacts on Metabolite Profiles of Airway Samples from Cystic Fibrosis Patients. mSystems (2017) 0.75

A Broad-Host-Range Tailocin from Burkholderia cenocepacia. Appl Environ Microbiol (2017) 0.75